Livzym Biotechnologies
PrivateLast Round
VC Round
Aug 15, 2024
Est. Valuation
$60M
Company Overview
Livzym Biotechnologies is an industrial biotechnology company that develops and produces enzymes for the food, animal feed, textile, and paper industries using a fungi-based precision fermentation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Livzym Biotechnologies Comparables
Compare Livzym Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aumgene Biosciences Private Limited | 79% | |
| Advanced Enzyme Technologies Limited | 73% | |
| Liberation Bioindustries | 72% |
Livzym Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 15, 2024 | ||||
| VC Round | Oct 1, 2022 |
Livzym Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kalkınma Girişim Sermayesi Portföy Yönetimi A.Ş. | VC Round |
| Türk Telekom Ventures | VC Round |
| Danstar Ferment AG | VC Round |
| StartupIst Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 5162% MoM, from 29 to 1.5K.
- Nov 9, 2025
Monthly visitors increased 63% MoM, reaching 1K.
Livzym Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Livzym Biotechnologies's valuation, stock price, and market status.
Is Livzym Biotechnologies a public or private company?
Livzym Biotechnologies is a private company.
What is the current stock price of Livzym Biotechnologies?
Livzym Biotechnologies is a private company with no public stock price. Caplight tracks Livzym Biotechnologies's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Livzym Biotechnologies worth (valuation)?
Livzym Biotechnologies's valuation is estimated at $60.0M based on funding round data.
Can I buy Livzym Biotechnologies stock?
Livzym Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Livzym Biotechnologies's last funding round?
Livzym Biotechnologies's most recent funding round was VC Round on August 15, 2024.
Who are the main investors in Livzym Biotechnologies?
Key investors in Livzym Biotechnologies include Kalkınma Girişim Sermayesi Portföy Yönetimi A.Ş., Türk Telekom Ventures, Danstar Ferment AG, StartupIst Ventures.
Will Livzym Biotechnologies IPO soon?
No public IPO plans have been announced for Livzym Biotechnologies.
How can I track Livzym Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Livzym Biotechnologies's secondary market activity and sign up for updates.